Literature DB >> 24862965

Office gel sonovaginography for the prediction of posterior deep infiltrating endometriosis: a multicenter prospective observational study.

S Reid1, C Lu, N Hardy, I Casikar, G Reid, G Cario, D Chou, D Almashat, G Condous.   

Abstract

OBJECTIVE: To use office gel sonovaginography (SVG) to predict posterior deep infiltrating endometriosis (DIE) in women undergoing laparoscopy.
METHODS: This was a multicenter prospective observational study carried out between January 2009 and February 2013. All women were of reproductive age, had a history of chronic pelvic pain and underwent office gel SVG assessment for the prediction of posterior compartment DIE prior to laparoscopic endometriosis surgery. Gel SVG findings were compared with laparoscopic findings to determine the diagnostic accuracy of office gel SVG for the prediction of posterior compartment DIE.
RESULTS: In total, 189 women underwent preoperative gel SVG and laparoscopy for endometriosis. At laparoscopy, 57 (30%) women had posterior DIE and 43 (23%) had rectosigmoid/anterior rectal DIE. For the prediction of rectosigmoid/anterior rectal (i.e. bowel) DIE, gel SVG had an accuracy of 92%, sensitivity of 88%, specificity of 93%, positive predictive value (PPV) of 79%, negative predictive value (NPV) of 97%, positive likelihood ratio (LR+) of 12.9 and negative likelihood ratio (LR-) of 0.12 (P = 3.98E-25); for posterior vaginal wall and rectovaginal septum (RVS) DIE, respectively, the accuracy was 95% and 95%, sensitivity was 18% and 18%, specificity was 99% and 100%, PPV was 67% and 100%, NPV was 95% and 95%, LR+ was 32.4 and infinity and LR- was 0.82 and 0.82 (P = 0.009 and P = 0.003).
CONCLUSIONS: Office gel SVG appears to be an effective outpatient imaging technique for the prediction of bowel DIE, with a higher accuracy for the prediction of rectosigmoid compared with anterior rectal DIE. Although the sensitivity for vaginal and RVS DIE was limited, gel SVG had a high specificity and NPV for all forms of posterior DIE, indicating that a negative gel SVG examination is highly suggestive of the absence of DIE at laparoscopy.
Copyright © 2014 ISUOG. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  DIE; SVG; laparoscopy; office gel sonovaginography; posterior deep infiltrating endometriosis; sliding sign

Mesh:

Year:  2014        PMID: 24862965     DOI: 10.1002/uog.13422

Source DB:  PubMed          Journal:  Ultrasound Obstet Gynecol        ISSN: 0960-7692            Impact factor:   7.299


  5 in total

Review 1.  Imaging modalities for the non-invasive diagnosis of endometriosis.

Authors:  Vicki Nisenblat; Patrick M M Bossuyt; Cindy Farquhar; Neil Johnson; M Louise Hull
Journal:  Cochrane Database Syst Rev       Date:  2016-02-26

2.  Capacity building in endometriosis ultrasound: are we there yet?

Authors:  Uche A Menakaya
Journal:  Australas J Ultrasound Med       Date:  2015-12-31

3.  Intestinal endometriotic nodules with a length greater than 2.25 cm and affecting more than 27% of the circumference are more likely to undergo segmental resection, rather than linear nodulectomy.

Authors:  Helizabet Abdalla-Ribeiro; Marina Miyuki Maekawa; Raquel Ferreira Lima; Ana Luisa Alencar de Nicola; Francisco Cesar Martins Rodrigues; Paulo Ayroza Ribeiro
Journal:  PLoS One       Date:  2021-04-15       Impact factor: 3.240

Review 4.  The Application of Sonovaginography for Implementing Ultrasound Assessment of Endometriosis and Other Gynaecological Diseases.

Authors:  Francesca Arezzo; Gennaro Cormio; Daniele La Forgia; Adam Abdulwakil Kawosha; Michele Mongelli; Carmela Putino; Erica Silvestris; Donato Oreste; Claudio Lombardi; Gerardo Cazzato; Ettore Cicinelli; Vera Loizzi
Journal:  Diagnostics (Basel)       Date:  2022-03-27

5.  Sonographic Differential Diagnosis in Deep Infiltrating Endometriosis: The Bowel.

Authors:  Marco Scioscia; Simone Orlandi; Giamberto Trivella; Antonella Portuese; Stefano Bettocchi; Giovanni Pontrelli; Paolo Bocus; Bruna Anna Virgilio
Journal:  Biomed Res Int       Date:  2019-10-28       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.